Publikationen

2022

Goldinger SM, Buder-Bakhaya K, Lo SN, Forschner A, McKean M, Zimmer L, Khoo C, Dummer R, Eroglu Z, Buchbinder EI, Ascierto PA, Gutzmer R, Rozeman EA, Hoeller C, Johnson DB, Gesierich A, Kölblinger P, Bennannoune N, Cohen JV, Kähler KC, Wilson MA, Cebon J, Atkinson V, Smith JL, Michielin O, Long GV, Hassel JC, Weide B, Haydu LE, Schadendorf D, McArthur G, Ott PA, Blank C, Robert C, Sullivan R, Hauschild A, Carlino MS, Garbe C, Davies MA, Menzies AM. Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis. Eur J Cancer 2022, Feb;162:22-33. doi: 10.1016/j.ejca.2021.11.022.

​

2021

Haenssle HA, Winkler JK, Fink C, Toberer F, Enk A, Stolz W, Deinlein T, Hofmann-Wellenhof R, Kittler H, Tschandl P, Rosendahl C, Lallas A, Blum A, Abassi MS, Thomas L, Tromme I, Rosenberger A; Reader study level-I and level-II Groups (Buder-Bakhaya, K) Christina Alt. Skin lesions of face and scalp - Classification by a market-approved convolutional neural network in comparison with 64 dermatologists. Eur J Cancer 2021 Feb;144:192-199. doi: 10.1016/j.ejca.2020.11.034.

​

2020

Salzmann M, Benesova K, Buder-Bakhaya K, Papamichail D, Dimitrakopoulou-Strauss A, Lorenz HM, Enk AH, Hassel JC. Arthralgia Induced by BRAF Inhibitor Therapy in Melanoma Patients. Cancers (Basel). 2020 Oct 16;12(10):3004. doi: 10.3390/cancers12103004.

​

Haenssle HA, Fink C, Toberer F, Winkler J, Stolz W, Deinlein T, Hofmann-Wellenhof R, Lallas A, Emmert S, Buhl T, Zutt M, Blum A, Abassi MS, Thomas L, Tromme I, Tschandl P, Enk A, Rosenberger A; Reader Study Level I and Level II Groups (Buder-Bakhaya K). Man against machine reloaded: performance of a market-approved convolutional neural network in classifying a broad spectrum of skin lesions in comparison with 96 dermatologists working under less artificial conditions. Ann Oncol. 2020 Jan;31(1):137-143. doi: 10.1016

​

​

2019

Buder-Bakhaya K, Hakim-Meibodi LE, Mokry T, Winkler JK, Toberer F, Enk A, Hassel JC. Subcutaneous endometriosis mimicking melanoma metastasis. J Dtsch Dermatol Ges. 2019 Sep;17(9):939-941. doi: 10.1111/ddg.13837. 

​

Brinker TJ, Hekler A, Enk AH, Klode J, Hauschild A, Berking C, Schilling B, Haferkamp S, Schadendorf D, Holland-Letz T, Utikal JS, von Kalle C; Collaborators (Buder-Bakhaya, K). Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task. Eur J Cancer. 2019 May;113:47-54. doi: 10.1016.

​

Brinker TJ, Hekler A, Enk AH, Klode J, Hauschild A, Berking C, Schilling B, Haferkamp S, Schadendorf D, Fröhling S, Utikal JS, von Kalle C; Collaborators (Buder-Bakhaya, K). A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification task. Eur J Cancer. 2019 Apr;111:148-154. doi: 10.1016.

​

​

2018

Buder-Bakhaya K, Hassel JC. Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment-A Review From the Melanoma Perspective and Beyond. Front Immunol. 2018 Jun 28;9:1474. doi: 10.3389/

​

Haenssle HA, Fink C, Schneiderbauer R, Toberer F, Buhl T, Blum A, Kalloo A, Hassen ABH, Thomas L, Enk A, Uhlmann L; Reader study level-I and level-II Groups, Alt C, Arenbergerova M, Bakos R, Baltzer A, Bertlich I, Blum A, Bokor-Billmann T, Bowling J, Braghiroli N, Braun R, Buder-Bakhaya K, Buhl T, Cabo H, Cabrijan L, Cevic N, Classen A, Deltgen D, Fink C, Georgieva I, Hakim-Meibodi LE, Hanner S, Hartmann F, Hartmann J, Haus G, Hoxha E, Karls R, Koga H, Kreusch J, Lallas A, Majenka P, Marghoob A, Massone C, Mekokishvili L, Mestel D, Meyer V, Neuberger A, Nielsen K, Oliviero M, Pampena R, Paoli J, Pawlik E, Rao B, Rendon A, Russo T, Sadek A, Samhaber K, Schneiderbauer R, Schweizer A, Toberer F, Trennheuser L, Vlahova L, Wald A, Winkler J, Wölbing P, Zalaudek I. Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists. Ann Oncol. 2018 Aug 1;29(8):1836-1842. doi: 10.1093.

​

Gaiser M.R., Weis C.A., Gaiser T., Jiang H., Buder-Bakhaya K., Herpel E., Warth A., Xiao Y., Miao L., Brownell I. Merkel cell carcinoma expresses the immunoregulatory ligand CD200 and induces immunosuppressive macrophages and regulatory T cells. Oncoimmunology, 2018 Feb 8;7(5):e1426517. doi: 10.1080.

​

Machiraju D., Moll I., Gebhardt C., Sucker A., Buder-Bakhaya K., Schadendorf D., Hassel J.C.  STAT5 expression correlates with recurrence and survival in melanoma patients treated with interferon-alpha. Melanoma Research, 2018 Jun;28(3):204-210. doi: 10.1097.

​

​

2017

Hassel, J.C., Buder-Bakhaya, K. (shared first author), Bender, C., Zimmer, L., Weide, B., Loquai, C., Ugurel, S., Slynko, A., Gutzmer, R. Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanoma. Cancer Med 2017. Dec 20. DOI: 10.1002/cam4.1267.

​

Buder-Bakhaya K., Benesova K., Schulz C., Anwar H., Dimitrakopoulou-Strauss A., Weber T.F., Enk A., Lorenz H.-M., Hassel J.C. Characterization of arthralgia induced by PD-1 antibody treatment in patients with metastasized cutaneous malignancies. Cancer Immunology and Immunotherapy 2017; DOI: 10.1007/s00262-017-2069-9.

​

Winkler, J.K., Buder-Bakhaya K., Dimitrakopoulou-Strauss A., Enk A.H., Hassel J.C. Malignes Melanom – aktueller Stand. Der Radiologe; 2017; Jul 20. DOI: 10.1007/s00117-017-0281-4.

​

Buder-Bakhaya K., Machiraju, D., Hassel J.C.: Liquid biopsy: value for melanoma therapy? Oncol Res Treat 2017;40(7-8):430-434.

​

Winkler J.K., Buder-Bakhaya K., Ellert E., Herpel E., Martens U.M., Enk A., Hassel J.C.: Acute heart failure as a result of granulomatous myocarditis: case report on a patient with metastatic melanoma treated with dabrafenib and trametinib. J Eur Acad Dermatol Venereol., 2017; Jul 11. doi: 10.1111/jdv.14467.

​

Toksoy A., Strifler S., Benoit S., Grigoleit G.U., Knop S., Mielke S., Buder-Bakhaya K., Roth S., Goebeler M., Rosenwald A., Geissinger E., Wobser M.: Facial Swelling and Hydroa Vacciniforme-like Skin Lesions in Epstein-Barr Virus-associated T-cell Lymphoproliferation with Subsequent Development of Lymphoma. Acta Derm Venereol. 2017;97 (3); 379-380.

​

​

2016

Buder-Bakhaya K., Hassel J.C.: Aktuelle Prinzipien der Immuntherapie am Beispiel des metastasierten Melanoms. Zeitschrift für Interdisziplinäre Krebsmedizin 2016; 25(6);380-388.

​

Buder-Bakhaya K., Hassel J.C.: Aktuelle Entwicklungen der Systemtherapie des fortgeschrittenen metastasierten Melanoms. TumorDiagn u Ther 2016; 37(08): 446-450.

​

Lengfeld J., Buder-Bakhaya K., Goebeler M., Wobser M.: Bisphosphonate-Mediated Oral Ulcers: A Rare Differential Diagnosis of Erosive Oral Lesions. Dermatology 2016; 232(1):117-21.

​

​

2014

Buder, K.: „Primär kutanes T-Zell-Lymphom: 10 Fragen – 10 Antworten“. Springer Verlag, Heidelberg, 12/2014 (Beilage in „Der deutsche Dermatologe“, Januar 2015)

​

Buder K., Hamm H.: Residents' corner. Nail it! A bleeding tumour at the fingertip. Eur J Dermatol 2014; Oct 1;24(5):637-8.

​

Buder K., Lapa C., Kreissl M.C., Schirbel A., Herrmann K., Schnack A., Bröcker E.B., Goebeler M, Buck A.K., Becker J.C.: Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging. BMC Cancer 2014 Apr 17;14(1):268.

​

Buder K., Hamm H.: Residents' corner. Nail it! Eye-catching nail folds. Eur J Dermatol 2014; Mar-Apr;24(2):283-4.

​

Buder K., Ruppert S., Trautmann A., Bröcker E.-B., Goebeler M., Kerstan A.: Angiolymphoid hyperplasia with eosinophilia and Kimura's disease – a clinical and histopathological comparison. J Dtsch Dermatol Ges. 2014 Mar;12(3):224-8.

​

Buder K., Müller P.A., Beckmann G., Ugurel S., Bröcker E.-B., Becker, J.C.: Denileukin Diftitox and total skin electron beam radiation in cutaneous T-cell-Lymphoma (Mycosis fungoides): case series of 4 patients. Acta Derm Venerol; 2014 Jan 8;94(1):94-96.

​

​

2013

Buder K., Gesierich A., Gelbrich G., Goebeler M.: Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives. Cancer Medicine 2013; 2(5):674-686.

​

Buder K., Poppe L.M., Bröcker E.-B., Goebeler M., Rosenwald A., Geissinger E., Kerstan A.: Primary cutaneous follicular helper T-cell lymphoma – diagnostic pitfalls of this new lymphoma subtype. J Cutan Pathol. 2013;40(10):903-8.

​

Buder K., Motschenbacher S.: Residents' corner. Nail it! Painful toe nails in a young patient, Eur J Dermatol 2013; Sep-Oct;23(5):744-5.

​

Buder K., Hamm H.: Residents' corner. sQUIZ your knowledge! Eur J Dermatol 2013; Jun 1;23(3):432-3.

​

Buder K., Kolb-Mäurer A.: Residents' corner. Nail it! – Sudden nail loss. Eur J Dermatol 2013; Apr 1;23(2):294.

           

Buder K., Wendel A.M., Cerroni L., Goebeler M., Kerstan A.: A case of regional lymphompatoid papulosis limited to Becker’s melanosis. Dermatology 2013; 226(2):124-7.

​

​

2012

Motschenbacher, S., Buder, K., Goebeler M., Kerstan A.: Combined oral alitretinoin and narrowband UVB treatment of cutaneous T-cell lymphoma: favourable response after multiple ineffective systemic therapies. Eur J Dermatol 2012; 22(6):803-804.

​

​

2010

Buder, K., Knuschke, P., Wozel, G.: Evaluation of Methylprednisolone aceponate, Tacrolimus and Combination thereof in the Psoriasis Plaque Test using Sum Score, 20-MHz-Ultrasonography and Optical Coherence Tomography. Int J Clin Pharmacol Ther 2010; 48:814-820.

​

Buder, K. and Wozel, G.: Psoriatic arthritis: a diagnostic challenge? G Ital Dermatol Venereol 2010; 145:407-413.